文档介绍：临床与实践 Linchuangyushijian 《中外医学研究》第 20 卷 第 7 期（总第 519 期）2022 年 3 月
康妇炎胶囊联合左氧***沙星、甲硝唑治疗盆腔炎l effective rate of treatment in observation group was %, which was higher
than % in control group (P<). After treatment, the levels of interleukin (IL)- 2 and IL-10 in observation group were higher
than those in control group, and the level of tumor necrosis factor-α (TNF-α) was lower than that in control group (P<). There was
no significant difference in the incidence of adverse reactions between the two groups (P>). The recurrence rate of the observation
group was % (2/75) in the two-month follow-up, which was significantly lower than % (9/60) of the control group (P<). The
scores of all dimensions of the quality of life of the observation group after treatment were higher than those of the control group (P<).
Conclusion: Kangfuyan Capsule combined with Levofloxacin and Metronidazole in the treatment of patients with pelvic inflammatory
disease can not only effectively enhance the treatment efficiency and reduce the recurrence rate, but also improve the inflammation level of
the patients, with high safety, and it is beneficial to improve the quality of life of patients and improve the prognosis. It has good application
value and is worthy of promotion in clinical practice.
[Key words] Kan